The TRIANKLE consortium will develop 3D bioprinted personalized scaffolds for tissue regeneration of ankle joints. High profile consortium partners include bioprinting firm CELLINK, Barcelona-based technological center Leitat and the popular sports club FC Barcelona.
Barça is taking part in the project through the health area of the Barça Innovation Hub. The club’s main role will be to perform preclinical assessments of these implants and offer evaluations of patient groups such as its amateur athletes and the FC Barcelona Players Association, as well as contribute to the dissemination and promotion of the program. It all fits perfectly with one of the principles of the BIHUB, for its projects contribute not only to improving the club, but also the world of sport and society at large.
This ambitious research project in regenerative medicine has an overall budget of €5.9M and will be developed over 4 years, starting in January 2021. CELLINK´s portion of the grant is. €622,000 of which the EU accounts for 100 percent of the costs. With CELLINK’s support, the consortium aims to create innovative personalized collagen- and gelatine-based implants manufactured with 3D bioprinting technology for patients with tendinopathies such as Achilles tendon partial ruptures and cartilage injuries.
Overall, TRIANKLE consortium consists of a team of 12 organizations covering the complete spectrum from advanced research to the market. Its main strength relies on the combination of highly skilled partners with proven track records in biomaterials for regenerative applications and 3D bioprinting technology. Partners are also devoted to social engagement and dissemination of results to healthcare professionals and, ultimately, potential patients.
The partnership includes one industry partner (Naturin Viscofan GmbH), three SMEs (CELLINK AB, Cambridge Nanomaterials Technology, and Gradocell SL), two research centres (Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. and Acondicionamiento Tarrasense Associacion), three universities (University of Stuttgart, Universidad del País Vasco and Eindhoven University of Technology), two non-profit organisations (Futbol Club Barcelona Asociacion FCB and Osteoarthritis Foundation International OAFI) and one healthcare institution (Fundacio Clinic per a la Recerca Biomedica). The TRIANKLE project coordinator is Naturin Viscofan GmbH.
The TRIANKLE project is working to unlock the potential of innovative 3D printing technology for regenerative medical applications and ultimately enable the commercialization of personalized regenerative solutions. Furthermore, the innovation potential of TRIANKLE lies in the launching of the technological platform that will enable the development of future regenerative therapies of joint tissues in weight-bearing joints.